A detailed history of Corient Capital Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,141 shares of TECH stock, worth $223,890. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,141
Previous 3,133 0.26%
Holding current value
$223,890
Previous $1.09 Million 0.28%
% of portfolio
0.08%
Previous 0.08%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $2,260 - $3,134
8 Added 0.26%
3,141 $1.09 Million
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $19,682 - $27,428
-61 Reduced 1.91%
3,133 $1.09 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $182,940 - $252,187
517 Added 19.31%
3,194 $1.38 Million
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $580,222 - $667,876
1,272 Added 90.53%
2,677 $1.39 Million
Q3 2021

Nov 16, 2021

BUY
$444.87 - $538.88 $74,738 - $90,531
168 Added 13.58%
1,405 $681,000
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $89,477 - $104,010
231 Added 22.96%
1,237 $557,000
Q1 2021

May 17, 2021

BUY
$314.62 - $411.0 $316,507 - $413,466
1,006 New
1,006 $384,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.